Please assess the completion status of the following clinical trial:

Trial Title: Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and Inflammation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~1. Adults 18 years and greater~2. Healthy~Exclusion criteria:~1. PVC \< 30~2. Hypertensive subjects on ACE inhibitors~3. Pregnant or nursing mothers~4. Diabetic with HbA1C \> 7.5 or stigmata of end organ damage (neuropathy, retinopathy, nephropathy, cardiomyopathy)~5. Cholesterol \> 30 mg/dL above NCEP accepted level based on cardiac risk.~6. Triglycerides \> 200~7. Previously diagnosed obstructive coronary artery disease, myocardial infarction or left ventricular dysfunction (with or without a history of congestive heart failure)~8. Renal insufficiency (Creatinine ≥ 1.5 mg/dl)~9. History of cerebrovascular disease~10. Any chronic inflammatory disease (rheumatologic, inflammatory bowel disease, etc)~11. Uncontrolled Stage 2 Hypertension (160/100 mmHg), or end organ damage due to hypertension (left ventricular hypertrophy, atrial fibrillation, hematuria, renal insufficiency, prior cerebrovascular disease).~12. Angiotensin converting enzyme inhibitor use~13. Coagulopathy (INR ≥ 1.5, PTT ≥ 1.5 x control)~14. Other chronic medical illnesses at the discretion of the investigators

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Bradykinin (Type: EXPERIMENTAL): Patients will have flow mediated vasodilation and radial artery tonometry performed. They will then receive 0, 10, 20, 40 ng/100cc/min of intrabrachial bradykinin. Strain gauge plethysmography and blood sampling at each dose will be done to evaluate t-PA release. Blood will also be drawn for other biomarkers.

Based on this trial design, predict the completion outcome and termination type (if applicable).